Madrid-based Medsavana uses NLP and machine learning to convert electronic medical records into real-world evidence.
Founded in 2014 in Madrid, Spain, Medsavana, S.L. uses Natural Language Processing and machine learning to turn electronic medical records into actionable real-world evidence for healthcare providers and life sciences firms. Its multi-language platform complies with the OMOP Common Data Model and serves pharmaceutical firms and providers in Europe, North America and Latin America. The company has raised EUR 23.00 mn across three deals, most recently on April 5, 2022, led by Buenavista Equity Partners. CEO David Flores is a co-founder.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in